3rd Quarter - Report — ACHAOGEN for ACHAOGEN (2018)

Firm

ACHAOGEN

Client

ACHAOGEN

Income

—

Expenses

$60,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Public Health and Bio threat issues as it pertains to antibiotics Hospital reimbursement for antibiotics ( NTAP and DRG) BARDA funding and other private/public funding issues

Foreign entity interest: Mrs.

Lobbyist	Covered position, as disclosed
STEPHANIE DYSON	—

Contacted: White House Office; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

REVAMP- antibiotic pull incentive DISARM- antibiotic reimbursement Hospital reimbursement ( NTAP and DRG) BARDA funding PAHPA reauthorization as it pertains to antibiotics

Lobbyist	Covered position, as disclosed
STEPHANIE DYSON	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); White House Office; Health & Human Services, Dept of (HHS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.